Celorrio, Marta <br/><br/>
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.  [electronic resource] 

 -  Brain, behavior, and immunity  Oct 2016 
 - 94-105 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1090-2139 
<br/><br/><label>Standard No.: </label>10.1016/j.bbi.2016.06.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidohydrolases--antagonists & inhibitors<br/>Animals<br/>Arachidonic Acids--metabolism<br/>Benzamides--administration & dosage<br/>Cannabinoid Receptor Agonists--metabolism<br/>Carbamates--administration & dosage<br/>Disease Models, Animal<br/>Endocannabinoids--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Parkinsonian Disorders--drug therapy<br/>Polyunsaturated Alkamides--metabolism<br/>Receptor, Cannabinoid, CB1--antagonists & inhibitors<br/>Receptor, Cannabinoid, CB2--antagonists & inhibitors